N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide

C104H126N22O11 — CID 161374105

IUPACN,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide
SMILESCNC(=O)c1cc(C)nc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.CNC(=O)c1cc(CC2CCC(Oc3cc(N4CC5CC(C4)O5)cc4nccnc34)CC2)ncn1.COCc1cc(CC2CCC(Oc3cc(N4CC5CC(C4)O5)cc4nccnc34)CC2)nc(C)n1.Cc1ncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1C
InChIInChI=1S/C27H33N5O3.C26H30N6O3.C26H32N6O3.C25H31N5O2/c1-17-30-19(10-20(31-17)16-33-2)9-18-3-5-22(6-4-18)35-26-12-21(11-25-27(26)29-8-7-28-25)32-14-23-13-24(15-32)34-23;1-27-26(33)23-9-17(30-15-31-23)8-16-2-4-19(5-3-16)35-24-11-18(10-22-25(24)29-7-6-28-22)32-13-20-12-21(14-32)34-20;1-17-13-22(26(33)27-2)31-24(30-17)14-18-3-5-20(6-4-18)35-23-16-19(32-9-11-34-12-10-32)15-21-25(23)29-8-7-28-21;1-17-18(2)29-20(16-28-17)13-19-3-5-22(6-4-19)32-24-15-21(30-9-11-31-12-10-30)14-23-25(24)27-8-7-26-23/h7-8,10-12,18,22-24H,3-6,9,13-16H2,1-2H3;6-7,9-11,15-16,19-21H,2-5,8,12-14H2,1H3,(H,27,33);7-8,13,15-16,18,20H,3-6,9-12,14H2,1-2H3,(H,27,33);7-8,14-16,19,22H,3-6,9-13H2,1-2H3
InChIKeyVQVVAQNYVRMMSW-UHFFFAOYSA-N
MW1860.29 g/mol
LogP14.13
Rot. Bonds24

About N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide

N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide (PubChem CID 161374105) has the molecular formula C104H126N22O11 and a molecular weight of 1860.29 g/mol. Its IUPAC name is N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide.

Molecular Properties

Compound NameN,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide
PubChem CID161374105
Molecular FormulaC104H126N22O11
Molecular Weight1860.29 g/mol
Exact Mass1859.00
IUPAC NameN,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide
SMILESCNC(=O)c1cc(C)nc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.CNC(=O)c1cc(CC2CCC(Oc3cc(N4CC5CC(C4)O5)cc4nccnc34)CC2)ncn1.COCc1cc(CC2CCC(Oc3cc(N4CC5CC(C4)O5)cc4nccnc34)CC2)nc(C)n1.Cc1ncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1C
InChIInChI=1S/C27H33N5O3.C26H30N6O3.C26H32N6O3.C25H31N5O2/c1-17-30-19(10-20(31-17)16-33-2)9-18-3-5-22(6-4-18)35-26-12-21(11-25-27(26)29-8-7-28-25)32-14-23-13-24(15-32)34-23;1-27-26(33)23-9-17(30-15-31-23)8-16-2-4-19(5-3-16)35-24-11-18(10-22-25(24)29-7-6-28-22)32-13-20-12-21(14-32)34-20;1-17-13-22(26(33)27-2)31-24(30-17)14-18-3-5-20(6-4-18)35-23-16-19(32-9-11-34-12-10-32)15-21-25(23)29-8-7-28-21;1-17-18(2)29-20(16-28-17)13-19-3-5-22(6-4-19)32-24-15-21(30-9-11-31-12-10-30)14-23-25(24)27-8-7-26-23/h7-8,10-12,18,22-24H,3-6,9,13-16H2,1-2H3;6-7,9-11,15-16,19-21H,2-5,8,12-14H2,1H3,(H,27,33);7-8,13,15-16,18,20H,3-6,9-12,14H2,1-2H3,(H,27,33);7-8,14-16,19,22H,3-6,9-13H2,1-2H3
InChIKeyVQVVAQNYVRMMSW-UHFFFAOYSA-N
XLogP14.13
TPSA360.47 Ų
H-Bond Donors2
H-Bond Acceptors31
Rotatable Bonds24
Heavy Atoms137
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001860.29
LogP ≤ 514.13
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1031

Analyze N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

methyl 6-methyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxylate
CID 157357366
N-methyl-2-[[4-(7-morpholin-4-ylquinazolin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;molecular hydrogen
CID 159374794
4-[8-[4-[(2-methylpyrimidin-5-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 158858413
N-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]acetamide
CID 121335573
4-[8-[4-[(2,5-dimethylpyrimidin-4-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 158204207
N-methyl-6-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]amino]pyridine-2-carboxamide
CID 121335836
methyl 4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexane-1-carboxylate
CID 86282798
N,N-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidin-4-amine
CID 147864127
4-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide
CID 90443995
4-[8-[4-[(2-chloropyrimidin-4-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 157161500
2-[5-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidin-2-yl]propan-2-ol
CID 161213116
4-[8-[4-[(2-methoxy-3-pyridinyl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine
CID 159654436

Frequently Asked Questions

What is the IUPAC name of N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide?
The IUPAC name of N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide (CID 161374105) is N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide.
What is the SMILES notation for N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide?
The canonical SMILES for N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide is CNC(=O)c1cc(C)nc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)n1.CNC(=O)c1cc(CC2CCC(Oc3cc(N4CC5CC(C4)O5)cc4nccnc34)CC2)ncn1.COCc1cc(CC2CCC(Oc3cc(N4CC5CC(C4)O5)cc4nccnc34)CC2)nc(C)n1.Cc1ncc(CC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1C.
What is the InChIKey of N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide?
The InChIKey is VQVVAQNYVRMMSW-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H33N5O3.C26H30N6O3.C26H32N6O3.C25H31N5O2/c1-17-30-19(10-20(31-17)16-33-2)9-18-3-5-22(6-4-18)35-26-12-21(11-25-27(26)29-8-7-28-25)32-14-23-13-24(15-32)34-23;1-27-26(33)23-9-17(30-15-31-23)8-16-2-4-19(5-3-16)35-24-11-18(10-22-25(24)29-7-6-28-22)32-13-20-12-21(14-32)34-20;1-17-13-22(26(33)27-2)31-24(30-17)14-18-3-5-20(6-4-18)35-23-16-19(32-9-11-34-12-10-32)15-21-25(23)29-8-7-28-21;1-17-18(2)29-20(16-28-17)13-19-3-5-22(6-4-19)32-24-15-21(30-9-11-31-12-10-30)14-23-25(24)27-8-7-26-23/h7-8,10-12,18,22-24H,3-6,9,13-16H2,1-2H3;6-7,9-11,15-16,19-21H,2-5,8,12-14H2,1H3,(H,27,33);7-8,13,15-16,18,20H,3-6,9-12,14H2,1-2H3,(H,27,33);7-8,14-16,19,22H,3-6,9-13H2,1-2H3.
What are the key properties of N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide?
N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide has a molecular weight of 1860.29 g/mol, XLogP of 14.13, 24 rotatable bonds, 2 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for N,6-dimethyl-2-[[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]methyl]pyrimidine-4-carboxamide;4-[8-[4-[(5,6-dimethylpyrazin-2-yl)methyl]cyclohexyl]oxyquinoxalin-6-yl]morpholine;3-[8-[4-[[6-(methoxymethyl)-2-methylpyrimidin-4-yl]methyl]cyclohexyl]oxyquinoxalin-6-yl]-6-oxa-3-azabicyclo[3.1.1]heptane;N-methyl-6-[[4-[7-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)quinoxalin-5-yl]oxycyclohexyl]methyl]pyrimidine-4-carboxamide is sourced from PubChem (CID 161374105), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).